Abstract |
Pseudoephedrine and triprolidine, administered every 6 hours as a combination, made separate and distinct contributions to the treatment of allergic rhinitis. Furthermore, the combination was perceived by the patients as being clinically superior to either of its components or placebo.
|
Authors | J T Connell, B O Williams, S Allen, A Cato, J G Perkins |
Journal | The Journal of international medical research
(J Int Med Res)
Vol. 10
Issue 5
Pg. 341-7
( 1982)
ISSN: 0300-0605 [Print] England |
PMID | 6128282
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Drug Combinations
- Histamine H1 Antagonists
- Placebos
- Pyridines
- pseudoephedrine, triprolidine drug combination
- Triprolidine
- Pseudoephedrine
- Ephedrine
|
Topics |
- Clinical Trials as Topic
- Double-Blind Method
- Drug Combinations
(therapeutic use)
- Ephedrine
(therapeutic use)
- Histamine H1 Antagonists
(therapeutic use)
- Humans
- Placebos
- Pseudoephedrine
- Pyridines
(therapeutic use)
- Rhinitis, Allergic, Seasonal
(drug therapy)
- Triprolidine
(therapeutic use)
|